SRI Blog

Biomedical Sciences and Health

Thomas VossThomas Voss Aug 26, 2015

Researchers in SRI Biosciences’ infectious disease group are working to develop diagnostic tests, vaccines, and therapies that can help medical professionals around the world more effectively treat frightening and deadly illnesses.

Kathlynn BrownKathlynn Brown Aug 14, 2015

My group at SRI Biosciences is driven by the idea of a “magic bullet” drug that can home in on a particular cell type and avoid healthy cells. This notion of a magic bullet has been around for 100 years, but finding molecules that recognize the address of a particular cell is challenging. In other...

Kathleen HebbelerKathleen Hebbeler May 27, 2015

The findings of our recently completed study show that there is a lot of room for improvement.

Peter KarpPeter Karp Feb 11, 2015

Sequencing an organism’s genome is an important step in understanding how an organism functions. Learn about some of the latest advances.

Peter KarpPeter Karp Dec 9, 2014

Researchers in a broad range of fields, from biotech to agriculture, use MetaCyc content to study organism pathways and metabolism. Its applications range from green chemicals to reducing climate change to improving human health to wine making.

David SahnerDavid Sahner Dec 4, 2014

SRI is particularly proud that this new facility—along with our productive collaboration with MEDC—will benefit a number of organizations and individuals as well as the greater community.

Annalisa D’AndreaAnnalisa D’Andrea Sep 4, 2014

Learn how researchers in SRI Biosciences have identified a small molecule that looks like a promising therapy for psoriasis, an autoimmune disease of the skin affecting approximately two percent of the population.

David SahnerDavid Sahner Jun 12, 2014

SRI's newest facility will meet an important translational need for government and industry clients and partners, particularly small biotech companies that need early-stage human clinical trial services.

Ajay DivakaranAjay Divakaran Jun 5, 2014

Our recent work in food recognition uses vision technology to record and quantify food items to help people make more informed eating decisions.

Lucia BevigliaLucia Beviglia May 23, 2014

SRI Biosciences researchers have developed an advanced xenograft model for testing novel therapies. A lack of preclinical models that accurately mimic cancer and predict how well a compound may work in people is a key reason most cancer treatments fail during clinical development.

Lidia SambucettiLidia Sambucetti Feb 19, 2014

For years, there has been a major unmet need for a more sensitive method for improved identification and characterization of rare circulating tumor cells (CTCs), blood markers that can identify tumors that are metastasizing and spreading.

Gita Shankar & Walter H. MoosGita Shankar & Walter H. Moos Nov 1, 2013

At SRI International, researchers are pursuing advances in antidotes and treatments such as oral medication that could be given to mass populations in the event of a disaster such as radiation exposure.

Stephen MorairtyStephen Morairty Jul 26, 2013

Researchers in SRI's Center for Neuroscience are searching for a biomarker that could help diagnose neurodegenerative diseases years before symptoms appear and brain damage is already extensive.

Rajeev VaidyanathanRajeev Vaidyanathan Jul 18, 2013

Bed bugs are truly egalitarian. In time, more incidents of bed bugs are expected in middle-class and higher-income homes. Now, let's talk about hard numbers and solutions.

Jennifer W. YuJennifer W. Yu May 20, 2013

DSM-5’s new Autism Spectrum Disorder (ASD) diagnosis is a significant change that can lead to more individualized diagnostic approaches for people with ASD. It may increase the sensitivity and clarity of clinicians’ diagnoses as they consider the needs, symptoms, and severity of each patient.

Denong WangDenong Wang May 8, 2013

SRI’s Tumor Glycome Laboratory has found a biomarker that identifies the most aggressive form of prostate cancer. Further study will confirm if a blood test can provide a much-needed tool to differentiate between aggressive cancer and the majority of cases which are slow-growing tumors.

Joseph Rogers Feb 8, 2013

SRI is taking an innovative approach that recognizes and attempts to address the emerging concept that Alzheimer’s could be a syndrome, with multiple causes and incestuously-interlocked effects.

Gary Swan Dec 17, 2012

Through twin studies, scientists understand the interplay between genetics and the environment in ways that the study of unrelated people–or even other types of siblings–is unable to do.

Rajeev VaidyanathanRajeev Vaidyanathan Dec 5, 2012

Bed bugs share our beds, feed on our blood at night, and they disappear by dawn, often leaving nothing more than a raised welt on our skin, a token of last night’s encounter. Why is it so hard to prevent and control them?

Jon C. Mirsalis Sep 13, 2012

Traditional pharmaceutical companies simply can’t afford to spend the $1 billion or more it takes to bring a drug all the way to market when the affected population is too poor to buy the drugs, or too small to make a dent in the investment. Organizations like SRI fill the gap.

Pages